Peptide questions · Follistatin-344
How long does Follistatin-344 take to work?
Reviewed Evidence: EmergingPublished by PepVault
Follistatin-344’s onset is unknown in people, its peak effect comes at unknown in people; the gene-therapy trials measured at 6 months and a year, and its typical duration is 10–30 days per community cycle, by the library’s timeline (backed by preliminary research).
The timeline’s basis: Mouse and primate work, plus small gene-therapy trials of the FS344 gene (not the injected protein) whose sIBM results drew a published rebuttal. For the injected peptide: one adverse-event case series and no efficacy data in people.
Follistatin-344 week by week
The library places five of its research notes on Follistatin-344 on the days they cover, from day 1 to day 90 and on: 2 on community reports, 2 on clinical data and 1 on randomized trials.
Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.
| When | The note | Evidence |
|---|---|---|
| Days 1–14 (weeks 1–2) | The first two weeks are quiet | Community report |
| Days 7–30 (weeks 1–5) | The eye signal, said plainly | Clinical data |
| Days 14–60 (weeks 2–9) | What follistatin has actually moved in people | Clinical data |
| Days 30–90 (weeks 5–13) | Bigger muscle, unchanged function | Randomized trial |
| From day 60 on | Past a month or two, nothing is mapped | Community report |

The Follistatin-344 timeline’s milestones
The library’s timeline for Follistatin-344 marks 7 points from week 1 to week 12, backed by preliminary research overall.
- Week 1: Commonly reported: injection-site redness and sometimes mild fatigue; muscle change is not something users report this early
- Week 2: Works by binding myostatin and activin A, the brakes on muscle growth; in mice, over-expressing follistatin in muscle matched the size of myostatin-knockout mice
- Week 3: Published for high single doses: eleven bodybuilders who injected whole 1 mg vials developed fluid under the retina, with blurred or distorted central vision; it cleared over about two months in those who injected once
- Week 4: Community cycles commonly end between 10 and 30 days with 3 to 4 weeks off; nothing published describes what repeated courses of the injected peptide do
- Week 6: In people, the follistatin that moved anything was a gene delivered into the quadriceps: six-minute walking distance improved in four of six men with Becker muscular dystrophy, with no change in two
- Week 8: A human lesson from the follistatin drug that did reach trials: injected into a muscle it grew that muscle by 9 to 16% without consistently improving what people could do with it
- Week 12: Its researchers say it needs sustained exposure to matter, which is what gene delivery was built for and what a fast-clearing injection is not
The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.
Why Follistatin-344 takes that long
The library states no half-life with a number for Follistatin-344 (it says: “Not measured in people: no human pharmacokinetic study of injected follistatin has been published. In rats, labelled follistatin given into a vein cleared in two phases, about 4 minutes then about 2 hours, and collected in the liver (Kogure 1996). Drug companies that tried to develop it found native follistatin cleared too fast to work as an injection and had to engineer around it. The 90-minute figure community guides quote has never been measured; the rat terminal value is about 131 minutes.”), so this page can’t work out a build-up; the timing rests on the notes above.
Follistatin-344 against other growth hormone compounds
The library holds an onset-and-peak timeline for 8 growth hormone compounds, Follistatin-344 among them; none of the others shares its onset of unknown in people.
| Compound | Onset | Peak effect |
|---|---|---|
| Ipamorelin | 1–2 weeks | 8–12 weeks |
| CJC-1295 with DAC | 1–3 weeks | 8–12 weeks |
| CJC-1295 no DAC | 1–2 weeks | 8–12 weeks |
| Sermorelin | 1–2 weeks | 3–6 months |
| MK-677 | 1–3 days | 8–12 weeks |
| IGF-1 LR3 | 1–7 days (user reports) | Unknown in people; the animal studies ran 7 to 14 days |
| PEG-MGF | Unknown; nothing systemic is reported | Unknown in people or animals |
| Follistatin-344 | Unknown in people | Unknown in people; the gene-therapy trials measured at 6 months and a year |
Questions people ask
How long does Follistatin-344 take to work?
Follistatin-344’s onset is unknown in people, its peak effect comes at unknown in people; the gene-therapy trials measured at 6 months and a year, and its typical duration is 10–30 days per community cycle, by the library’s timeline (backed by preliminary research).
When does Follistatin-344 reach its peak effect?
By the library’s timeline, Follistatin-344’s peak effect comes at unknown in people; the gene-therapy trials measured at 6 months and a year, backed by preliminary research.
How long is Follistatin-344 usually run?
The library’s timeline gives Follistatin-344’s typical duration as 10–30 days per community cycle; its cycle note says: Community cycles commonly run 10 to 30 days with 3 to 4 weeks off, on the reasoning that the peptide clears fast and the protein is expensive; none of that comes from a study.
What does the library say about the first days on Follistatin-344?
Its first note on Follistatin-344, for days 1–14 (weeks 1–2), is “The first two weeks are quiet”, resting on community reports.